Conference Coverage
Conference Coverage
Finerenone’s heart benefits hold up in T2D patients without CVD
In the FIDELIO-DKD trial, cardiovascular benefits from a nonsteroidal mineralocorticoid antagonist held, regardless of CVD history, in T2D...
Conference Coverage
Marijuana use tied to repeat MI, stroke after percutaneous coronary intervention
“It is absolutely critical” that cardiologists and general providers screen patients for marijuana use, “either at the time of their MI or ideally...
Latest News
Aspirin and statins in chronic hepatitis B: It’s complicated
Only statins showed consistent and significant dose-dependent reductions in the risk of HCC; cirrhosis dampened aspirin’s effect.
Conference Coverage
Pronounced racial differences in HBsAg loss after stopping nucleos(t)ide
Patients of White background had a nearly sixfold higher chance for functional cure of hepatitis B infection.
Conference Coverage
Harnessing the HIV care continuum model to improve HCV treatment success
Substance use, trauma histories, and mental health problems can negatively affect HCV care engagement.
Conference Coverage
Abnormal anal paps in people with HIV can go more than a year without follow-up
In the U.S., people living with HIV are 19 times more likely to develop anal cancer, according to a journal article.
Conference Coverage
‘Uptake is only the first step’ for effective HIV PrEP protection
Follow-up in patients who received HIV PrEP prescriptions through a Detroit program was under 50%.
Conference Coverage
Liver-related deaths decline after Medicaid expansion under ACA
Investment in Medicaid expansions paid off in fewer liver-related deaths and a decrease in racial/ethnic disparities.
Conference Coverage
Metapneumovirus infections clinically indistinguishable from flu, RSV
Conference Coverage
Osteoporosis drugs don’t worsen COVID-19 risk, may help
“What we observed is that there is no harm. Treatments should be continued.”